Zobrazeno 1 - 10
of 272
pro vyhledávání: '"BA Michel"'
Autor:
BA Michel
Publikováno v:
Swiss Medical Weekly, Vol 141, Iss 1920 (2011)
The new paradigm of therapy in rheumatoid arthritis is to aim toward early and complete remission, using a larger use of conventional DMARDs and biologic agents. The present recommendations were established through a consensus to help practitioners i
Externí odkaz:
https://doaj.org/article/0bf82564039646a28a6c3b746b9a5e1a
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum.
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum.
Publikováno v:
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.
Autor:
C Hagen, O Distler, U Müller-Ladner, A Carossino, RE Gay, R Nanagara, BA Michel, K Nishioka, M Matucci-Cerinic, S Gay
Publikováno v:
Speaker abstracts 2001.
Background Bucillamine (BUC) is an immunomodulatory drug used in the treatment of rheumatoid arthritis with inhibitory effects on B- and T-cell functions. However, the impact of Bucillamine on metabolic pathways of fibroblasts has not been addressed.
Publikováno v:
Speaker abstracts 2001.
Background Objectives In many investigations virus like particles (VLP) and especially type-C retroviruses could be activated from tumour cells in culture after stimulation with DNA damaging agents. Co-culture with H9 cells, a lymphatic cell line, ha
Publikováno v:
Speaker abstracts 2001.
Background L1 retrotransposons have been detected in rheumatoid arthritis (RA) at sites of joint destruction. Objectives To caracterise the L1 mRNA in RA. Methods RNA was isolated from the synovial tissue of a 35-years old woman with RA. The complete
Publikováno v:
Speaker abstracts 2001.
Background RA is a chronic disease characterised by tumour-like features such as synovial hyperplasia, invasive growth of the synovium and joint destruction. Maspin is a member of the serpin family of protease inhibitors with gene sequence similariti
Autor:
CA Seemayer, S Kuchen, M Neihart, P Kuenzler, E Neumann, M Pruschy, T Pap, WK Aicher, U Muller-Ladner, BA Michel, RE Gay, S Gay
Publikováno v:
Speaker abstracts 2001.
Background Objectives The aim of this study was to investigate, whether the destructive process of synovial fibroblasts in rheumatoid arthritis is dependent on the expression of p53. Moreover, we searched for the expression of p53 in RA-SF in vitro a
Publikováno v:
Speaker abstracts 2001.
Background The progression of the cell cycle is tightly controlled by cyclins and cyclin-dependent kinases. The p16Ink4a protein was identified as a specific inhibitor of cdk4. P16 inhibits the cdk4-dependent phosphorylation of the tumour suppressor